Atlas Trials

Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment

Clinical trial NCT02982642 · WITHDRAWN

Trial details

NCT number
NCT02982642
Sponsor
Dongzhimen Hospital, Beijing
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2017-01-01
Primary completion
2018-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.